Autonomix Medical expands IP portfolio with new U.S. patent
Newsdesk reports AMIX received a new U.S. patent covering feedback-guided precision neuromodulation and targeted therapy delivery.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.